Genes |
KO |
Enzyme |
Annotation |
Best Hit |
GWHGAAEX008356 |
K00901 |
dgkA, DGK |
diacylglycerol kinase (ATP) [EC:2.7.1.107] |
AT5G07920 |
GWHGAAEX011062 |
K00901 |
dgkA, DGK |
diacylglycerol kinase (ATP) [EC:2.7.1.107] |
AT2G20900 |
GWHGAAEX011148 |
K00901 |
dgkA, DGK |
diacylglycerol kinase (ATP) [EC:2.7.1.107] |
AT4G30340 |
GWHGAAEX014895 |
K00901 |
dgkA, DGK |
diacylglycerol kinase (ATP) [EC:2.7.1.107] |
AT5G57690 |
GWHGAAEX018921 |
K00901 |
dgkA, DGK |
diacylglycerol kinase (ATP) [EC:2.7.1.107] |
AT5G63770 |
GWHGAAEX011703 |
K01110 |
PTEN |
phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67] |
AT3G19420 |
GWHGAAEX007866 |
K01593 |
DDC, TDC |
aromatic-L-amino-acid/L-tryptophan decarboxylase [EC:4.1.1.28 4.1.1.105] |
AT2G20340 |
GWHGAAEX004666 |
K04392 |
RAC1 |
Ras-related C3 botulinum toxin substrate 1 |
AT5G45970 |
GWHGAAEX007538 |
K04392 |
RAC1 |
Ras-related C3 botulinum toxin substrate 1 |
AT4G35020 |
GWHGAAEX008376 |
K04392 |
RAC1 |
Ras-related C3 botulinum toxin substrate 1 |
AT4G28950 |
GWHGAAEX011135 |
K04392 |
RAC1 |
Ras-related C3 botulinum toxin substrate 1 |
AT5G62880 |
GWHGAAEX014914 |
K04459 |
DUSP, MKP |
dual specificity MAP kinase phosphatase [EC:3.1.3.16 3.1.3.48] |
AT2G04550 |
GWHGAAEX000187 |
K04505 |
PSEN1, PS1 |
presenilin 1 [EC:3.4.23.-] |
AT1G08700 |
GWHGAAEX013997 |
K04505 |
PSEN1, PS1 |
presenilin 1 [EC:3.4.23.-] |
AT2G29900 |
GWHGAAEX000127 |
K04688 |
RPS6KB |
ribosomal protein S6 kinase beta [EC:2.7.11.1] |
AT3G08720 |
GWHGAAEX011106 |
K04688 |
RPS6KB |
ribosomal protein S6 kinase beta [EC:2.7.11.1] |
AT3G08720 |
GWHGAAEX003958 |
K05099 |
MET, HGFR |
proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1] |
AT2G39890 |
GWHGAAEX001553 |
K07198 |
PRKAA, AMPK |
5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11] |
AT3G17510 |
GWHGAAEX003065 |
K07198 |
PRKAA, AMPK |
5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11] |
AT5G58380 |
GWHGAAEX004800 |
K07198 |
PRKAA, AMPK |
5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11] |
AT4G18700 |
GWHGAAEX009019 |
K07198 |
PRKAA, AMPK |
5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11] |
AT5G58380 |
GWHGAAEX009963 |
K07198 |
PRKAA, AMPK |
5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11] |
AT5G45810 |
GWHGAAEX012705 |
K07198 |
PRKAA, AMPK |
5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11] |
AT3G01090 |
GWHGAAEX018532 |
K07198 |
PRKAA, AMPK |
5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11] |
AT4G18700 |
GWHGAAEX005237 |
K07203 |
MTOR, FRAP, TOR |
serine/threonine-protein kinase mTOR [EC:2.7.11.1] |
AT1G50030 |
GWHGAAEX006860 |
K07203 |
MTOR, FRAP, TOR |
serine/threonine-protein kinase mTOR [EC:2.7.11.1] |
AT1G50030 |
GWHGAAEX004192 |
K10393 |
KIF2_24, MCAK |
kinesin family member 2/24 |
AT3G16060 |
GWHGAAEX005965 |
K10393 |
KIF2_24, MCAK |
kinesin family member 2/24 |
AT3G16630 |
GWHGAAEX000199 |
K11593 |
ELF2C, AGO |
eukaryotic translation initiation factor 2C |
AT2G27040 |
GWHGAAEX000395 |
K11593 |
ELF2C, AGO |
eukaryotic translation initiation factor 2C |
AT1G69440 |
GWHGAAEX003177 |
K11593 |
ELF2C, AGO |
eukaryotic translation initiation factor 2C |
AT1G69440 |
GWHGAAEX004590 |
K11593 |
ELF2C, AGO |
eukaryotic translation initiation factor 2C |
AT2G32940 |
GWHGAAEX006506 |
K11593 |
ELF2C, AGO |
eukaryotic translation initiation factor 2C |
AT1G48410 |
GWHGAAEX007790 |
K11593 |
ELF2C, AGO |
eukaryotic translation initiation factor 2C |
AT1G69440 |
GWHGAAEX009240 |
K11593 |
ELF2C, AGO |
eukaryotic translation initiation factor 2C |
AT1G48410 |
GWHGAAEX009851 |
K11593 |
ELF2C, AGO |
eukaryotic translation initiation factor 2C |
AT2G27040 |
GWHGAAEX010102 |
K11593 |
ELF2C, AGO |
eukaryotic translation initiation factor 2C |
AT5G43810 |
GWHGAAEX013766 |
K11593 |
ELF2C, AGO |
eukaryotic translation initiation factor 2C |
AT5G21150 |
GWHGAAEX013827 |
K11593 |
ELF2C, AGO |
eukaryotic translation initiation factor 2C |
AT1G48410 |